Welcome to our dedicated page for Owens & Minor news (Ticker: OMI), a resource for investors and traders seeking the latest updates and insights on Owens & Minor stock.
Owens & Minor, Inc. (NYSE: OMI) is a prominent healthcare logistics company specializing in the distribution and logistics of medical products. The company plays a crucial role in ensuring the seamless delivery of vital medical supplies from manufacturers to healthcare providers. With a presence in both the United States and Europe, Owens & Minor operates strategically positioned logistics platforms that serve markets responsible for three-quarters of global healthcare spending.
Headquartered in Richmond, Virginia, this Fortune 500 company boasts annualized revenues exceeding $9 billion. Owens & Minor's diverse customer base includes independent hospitals, large integrated healthcare networks, group purchasing organizations, healthcare product manufacturers, and the federal government.
Owens & Minor operates under two main segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment focuses on the manufacturing and sourcing of medical-surgical products. This segment also provides solutions to prevent healthcare-associated infections across various healthcare settings. On the other hand, the Patient Direct segment delivers disposable medical supplies directly to patients and home health agencies, enhancing the accessibility of essential healthcare products.
Recent achievements include strategic partnerships to expand their reach and optimize their supply chain operations. These initiatives aim to enhance service efficiency, ensuring that patients receive necessary medical supplies promptly and healthcare providers can focus on delivering quality care.
Owens & Minor's unwavering commitment to innovation and quality has positioned it as a leader in healthcare logistics. For more detailed information, visit their official website.
Owens & Minor (NYSE:OMI) announced that David R. Myers, Vice President of National Accounts, was inducted into the Bellwether League Foundation’s Hall of Fame for his contributions to the healthcare supply chain industry. Recognized for his customer-first philosophy and innovative supply strategies, Myers previously served as Chief Procurement Officer, enhancing partnerships during the pandemic. The induction ceremony will take place on October 3, 2022, in Milwaukee, joining a prestigious group of past honorees from Owens & Minor.
Owens & Minor, Inc. (NYSE: OMI) will release its second quarter 2022 financial results before market open on August 3, 2022. A conference call for investors is scheduled for 8:00 a.m. ET the same day, providing insights into the company's performance. Owens & Minor, operating since 1882, specializes in healthcare solutions, including product manufacturing and delivery, healthcare supply, and services. With over 20,000 employees, the company focuses on enhancing supply chain efficiency and improving patient care across various settings.
Owens & Minor (NYSE: OMI) announced the election of Carissa Rollins, former CIO of Illumina, to its Board of Directors effective July 12, 2022, continuing its multi-year Board succession process. Rollins brings over 30 years of experience in enterprise technology, previously leading significant projects at UnitedHealthcare. Mark F. McGettrick has stepped down from the Board on the same date. Both the Board Chair and CEO expressed confidence that Rollins' technical skills and strategic mindset will positively influence the company's growth.
Owens & Minor has commenced construction on a 350,000 sq. ft. center in Morgantown, West Virginia, set to open in late 2023. This facility will serve as a primary hub for medical supply logistics, enhancing healthcare resilience in the region. The project involves a $50 million investment and is expected to create over 100 jobs. This groundbreaking further solidifies the partnership between Owens & Minor and WVU Medicine, which aims to bolster response capabilities for public health emergencies.
Owens & Minor, Inc. (NYSE: OMI) has appointed Tammy Gomez as Executive Vice President & Chief Human Resources Officer effective July 11, 2022. Reporting to President and CEO Edward A. Pesicka, Gomez will lead the company's people strategy, focusing on talent retention, development, and engagement. She aims to enhance Owens & Minor’s culture and diversity initiatives. With over two decades of healthcare experience, including leadership roles at Cardinal Health, Gomez's appointment is expected to strengthen the company's workforce strategy.
Owens & Minor, Inc. (NYSE: OMI) announced the election of Rita Johnson-Mills and Terri Kline to its Board of Directors, effective June 1, 2022. Their extensive experience in healthcare is expected to enhance the Board's diversity and support long-term success. Johnson-Mills, with over 25 years in healthcare leadership, focuses on sustainable growth and employee engagement. Kline brings a robust background in various healthcare sectors, driving growth and M&A. Both leaders are poised to provide valuable insights for Owens & Minor's strategic direction.
Owens & Minor, Inc. (NYSE: OMI) has announced that its executive management team will present at the UBS Global Healthcare Conference on Monday, May 23rd at 11:30 AM ET. A live webcast and replay of the presentation will be available on their website in the investor relations section. With a history extending back to 1882, Owens & Minor is a global healthcare solutions company focused on product manufacturing and delivery, as well as home health supply services.
Owens & Minor, Inc. (NYSE: OMI) will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference on May 10th at 10:00 AM PT. The chat features CEO Ed Pesicka and CFO Andy Long.
Investors can access a live webcast and replay via Owens & Minor's website. The company, headquartered in Richmond, VA, integrates healthcare solutions and has been operational since 1882, employing over 20,000 people globally.
Owens & Minor reported a strong Q1 2022 with revenue of $2.4 billion, a 3.5% increase from Q1 2021. Patient Direct segment revenue surged 25.7%, buoyed by the recent acquisition of Apria, which is expected to contribute significantly to future earnings. GAAP EPS was $0.52, while adjusted EPS reached $0.96. The company revised 2022 guidance upward, anticipating revenue between $9.9 billion and $10.3 billion and adjusted EBITDA of $580 million to $630 million, aided by $180 million from Apria. However, elective procedure volumes are projected to remain slightly below pre-pandemic levels.
FAQ
What is the current stock price of Owens & Minor (OMI)?
What is the market cap of Owens & Minor (OMI)?
What does Owens & Minor, Inc. do?
Where is Owens & Minor headquartered?
What are the main segments of Owens & Minor's business?
Who are Owens & Minor's customers?
How much revenue does Owens & Minor generate annually?
What regions do Owens & Minor serve?
What recent achievements has Owens & Minor accomplished?
What is the focus of the Products & Healthcare Services segment?
What does the Patient Direct segment do?
Where can I find more information about Owens & Minor?
